|
|
|
| Strategies for Stem Cell Patent Evaluation and Patent Transfer and Transformation |
Yue-lei FAN,Jiao LU,Da-ming CHEN,Kai-yun MAO( ) |
| Shanghai Information Center for Life Sciences, Chinese Academy of Sciences,Shanghai 200031,China |
|
|
|
Abstract Objective: To construct an indicator model for stem cell patent evaluation and to analyze the factors affecting stem cell patent transfer and transformation in real scenarios besides the indicators.Methods:Based on the Patent Value Analysis Indicator System edited by China Technology Exchange, a patent evaluation system suitable for stem cells patents was constructed. The weight was determined by AHP, and the operability of the indicator model was verified by case analysis.Results:Based on the technical characteristics of stem cell technologies and operability, an indicator system for evaluating stem cell patents was constructed, which included three first-level indicators including technical value, market value and legal value, and nine second-level indicators such as technological advancement, technological maturity, technological cost, et al. Technological advancement, technological maturity, policy adaptability and market demand were the four most influential indicators for the valuation of stem cell patents. In the analysis of other factors, the core advantage of the stem cell technologies was the key to affect the transformation of stem cell patents. In addition, technical feasibility, quality control and long-term benefits also had important impact on the successful transfer and transformation of stem cell technologies.Conclusion:The patent value evaluation model and factor analysis established can be used in stem cell patent evaluation, which is helpful to promote the effective development and industrialization of the patent technology.
|
|
Received: 28 August 2018
Published: 28 February 2019
|
|
|
|
Corresponding Authors:
Kai-yun MAO
E-mail: kymao@sibs.ac.cn
|
|
|
| [1] |
Meuwissen H J, Gatti R A, Terasaki P I , et al. Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow. Crucial role of histocompatiility matching, New England Journal of Medicine, 1969,281(13):691-697.
doi: 10.1097/00007890-197006000-00011
|
|
|
| [2] |
Bacakova L, Zarubova J, Travnickova M , et al. Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells - a review. Biotechnology Advances, 2018,36(4):1111-1126.
doi: 10.1016/j.biotechadv.2018.03.011
|
|
|
| [3] |
Markets and Markets Editorial Committee. Stem Cell Manufacturing Market by Product (HSCs, MSCs, iPSCs, ESCs, Instruments, Media, Consumables), Application (Research, Target Identification, Therapy (Autologous, Allogeneic), Cell Banks), End User (Pharma, Hospitals) - Global Forecast to 2023.[ 2018-3-31].
|
|
|
| [4] |
霍国庆 . 我国科技成果转移转化的根本症结及其解决策略. 智库理论与实践, 2016,1(2):119-125.
doi: 10.19318/j.cnki.issn.2096-1634.2016.02.17
|
|
|
| [4] |
Huo G Q . The sticking points and solutions of China’s scientific and technological achievement transformation. Think Tank: Theory & Practice, 2016,1(2):119-125.
doi: 10.19318/j.cnki.issn.2096-1634.2016.02.17
|
|
|
| [5] |
全国人大常委会. 促进科技成果转化法修正案(草案)条文.[ 2018-3-31]. .促进科技成果转化法修正案(草案)条文.[2018-3-31]. .
|
|
|
| [5] |
Standing Committee of the National People’s Congress. Amendments to the law for promoting the transformation of scientific and technological achievements (Draft).[ 2018-3-31]. . Amendments to the law for promoting the transformation of scientific and technological achievements (Draft). [2018-3-31]. .
|
|
|
| [6] |
中国技术交易所. 专利价值分析指标体系操作手册.北京: 知识产权出版社, 2012: 5-32.
|
|
|
| [6] |
China Technology Exchange. Operating manual of patent value analysis index system. Beijing: Intellectual Property Publishing House, 2012: 5-32.
|
|
|
| [7] |
de Alvarenga E C, Silva W N, Vasconcellos R , et al. Promyelocytic leukemia protein in mesenchymal stem cells is essential for leukemia progression. Annals of Hematology, 2018,97(10):1749-1755.
doi: 10.1007/s00277-018-3463-x
|
|
|
| [8] |
Cao N, Liao T L, Liu J J , et al. Clinical-grade human umbilical cord-derived mesenchymal stem cells reverse cognitive aging via improving synaptic plasticity and endogenous neurogenesis.Cell Death & Disease, 8(8):e2996.
doi: 10.1038/cddis.2017.316
pmid: 28796260
|
|
|
| [9] |
高歌, 崔东 . 我国首批胚胎干细胞临床研究项目今日启动.[ 2017-4-11]. 我国首批胚胎干细胞临床研究项目今日启动.[2017-4-11]. .
|
|
|
| [9] |
Gao G, Cui D. The first clinical research projects on embryonic stem cells in China were launched today.[ 2017-4-11]. The first clinical research projects on embryonic stem cells in China were launched today. [2017-4-11]. .
|
|
|
| [10] |
丁建业, 陆毅 . 专利评估与层次分析法(AHP). 专利文献研究, 2007,6:1-7.
|
|
|
| [10] |
Ding J Y, Lu Y . Patent evaluation and analytic hierarchy process (AHP). Patent Literature Research, 2007,6:1-7.
|
|
|
| [11] |
Qiu X X, Liu Y, Zhang Y F , et al. Rapamycin and CHIR99021 coordinate robust cardiomyocyte differentiation from human pluripotent stem cells via reducing p53-dependent apoptosis. Journal of the American Heart Association, 2017,10(6):e005295.
doi: 10.1161/JAHA.116.005295
pmid: 5721819
|
|
|
| [12] |
Lu Q, Liu Y A, Wang Y , et al. Rapamycin efficiently promotes cardiac differentiation of mouse embryonic stem cells.[ 2017-6-7]. Rapamycin efficiently promotes cardiac differentiation of mouse embryonic stem cells.[2017-6-7]. .
|
|
|
| [13] |
厦门大学. 利用小分子化合物诱导干细胞向心肌分化的方法:中国.CN104447417A.2015-03-25[ 2018-08-18]. 利用小分子化合物诱导干细胞向心肌分化的方法:中国.CN104447417A.2015-03-25 [2018-08-18]. .
|
|
|
| [13] |
Xiamen University. Method for inducing cardiac differentiation of stem cells by utilizing small molecule compounds. CN104447417A.2015-03-25[ 2018-08-18]. Method for inducing cardiac differentiation of stem cells by utilizing small molecule compounds. CN104447417A.2015-03-25 [2018-08-18]. .
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
